Education
About Us
Working with TipRanks
Follow Us
Chordia Therapeutics Inc. (JP:190A)
:190A
RESEARCH TOOLSreports
190A Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥177.00 - ¥854.00
Previous CloseN/A
Volume2.20M
Average Volume (3M)692.63K
Market Cap
N/A
Enterprise Value¥12.84B
Total Cash (Recent Filing)¥4.33B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta0.27
Next Earnings
Oct 10, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.12
Shares Outstanding68,988,800
10 Day Avg. Volume328,700
30 Day Avg. Volume692,626
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Chordia Therapeutics Inc. News
190A FAQ
What was Chordia Therapeutics Inc.’s price range in the past 12 months?
Chordia Therapeutics Inc. lowest stock price was ¥177.00 and its highest was ¥854.00 in the past 12 months.
What is Chordia Therapeutics Inc.’s market cap?
Currently, no data Available
When is Chordia Therapeutics Inc.’s upcoming earnings report date?
Chordia Therapeutics Inc.’s upcoming earnings report date is Oct 10, 2025 which is in 49 days.
How were Chordia Therapeutics Inc.’s earnings last quarter?
Chordia Therapeutics Inc. released its earnings results on Jul 14, 2025. The company reported -¥6.12 earnings per share for the quarter, missing the consensus estimate of N/A by -¥6.12.
Is Chordia Therapeutics Inc. overvalued?
According to Wall Street analysts Chordia Therapeutics Inc.’s price is currently Overvalued.
Does Chordia Therapeutics Inc. pay dividends?
Chordia Therapeutics Inc. does not currently pay dividends.
What is Chordia Therapeutics Inc.’s EPS estimate?
Chordia Therapeutics Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Chordia Therapeutics Inc. have?
Chordia Therapeutics Inc. has 68,988,800 shares outstanding.
What happened to Chordia Therapeutics Inc.’s price movement after its last earnings report?
Chordia Therapeutics Inc. reported an EPS of -¥6.12 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.922%.
Which hedge fund is a major shareholder of Chordia Therapeutics Inc.?
Currently, no hedge funds are holding shares in JP:190A
Company Description
Chordia Therapeutics Inc.
Chordia is focused on the oncology area, with its target areas ranging from exploratory research to Proof of Concept (POC). For subsequent business development, we will build a system that allows us to make the best choices for maximizing corporate value, such as out-licensing and joint development and sales.
Technical Analysis
Nihon Chouzai Co
―
Pharmarise Holdings Corp.
―
Medical System Network Co., Ltd.
―
Tsubota Laboratory Incorporated
―
Astena Holdings Co.,Ltd.
―